Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness

Amiel A. Dror, Nicole G. Morozov, Amani Daoud, Yoav Namir, Yakir Orly, Yair Shachar, Mark Lifshitz, Ella Segal, Lior Fischer, Matti Mizrachi, Netanel Eisenbach, Doaa Rayan, Maayan Gruber, Amir Bashkin, Edward Kaykov, Masad Barhoum, Michael Edelstein, Eyal Sela
doi: https://doi.org/10.1101/2021.06.04.21258358
Amiel A. Dror
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: amieldror@gmail.com
Nicole G. Morozov
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amani Daoud
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoav Namir
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yakir Orly
4Statistical Analysis Division, Galilee Medical Center, Nahariya, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yair Shachar
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Lifshitz
5Computer Data Division, Galilee Medical Center, Nahariya, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ella Segal
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lior Fischer
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matti Mizrachi
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Netanel Eisenbach
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doaa Rayan
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maayan Gruber
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amir Bashkin
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
6Endocrinology unit, Galilee Medical Center, Nahariya, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Kaykov
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
7Geriatric Medicine Department, Galilee Medical Center, Nahariya, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masad Barhoum
8Galilee Medical Center, Nahariya, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Edelstein
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eyal Sela
1Department of Otolaryngology, Head and Neck Surgery, Galilee Medical Center, Nahariya, Israel
2Azrieli Faculty of Medicine, Bar-Ilan University, Safed, Israel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective Studies have demonstrated a potential link between low vitamin D levels and both an increased risk of infection with SARS-CoV-2 and poorer clinical outcomes but have not established temporality. This retrospective study examined if, and to what degree, a relationship exists between pre-infection serum vitamin D levels and disease severity and mortality of SARS-CoV-19.

Design and patients The records of individuals admitted between April 7th, 2020 and February 4th, 2021 to the Galilee Medical Center (GMC) in Nahariya, Israel with positive polymerase chain reaction (PCR) tests for SARS-CoV-2 were searched for vitamin D (VitD) levels measured 14 to 730 days prior to the positive PCR test.

Measurements Patients admitted to GMC with COVID-19 were categorized according to disease severity and VitD level. Association between pre-infection VitD levels and COVID-19 severity was ascertained utilizing a multivariate regression analysis.

Results Of 1176 patients admitted, 253 had VitD levels prior to COVID-19 infection. Compared with mildly or moderately diseased patients, those with severe or critical COVID-19 disease were more likely to have pre-infection vitamin D deficiency of less than 20 ng/mL (OR=14.30, 95%, 4.01-50.9; p < .001); be older (OR=1.039 for each year, 95% CI for OR, 1.017-1.061; p< .01), and have diabetes (OR=2.031, 95% CI for OR, 1.04-3.36; p= 0.038). Vitamin D deficiency was associated with higher rates of mortality (p<0.001) and comorbidities including COPD (p=0.006), diabetes (p=0.026), and hypertension (p=0.016).

Conclusions Among hospitalized COVID-19 patients, pre-infection deficiency of vitamin D was associated with increased disease severity and mortality.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding was not received.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Prior to study initiation, ethical approval was granted by the Research Ethics Committee of the Galilee Medical Center 0204-20-NHR.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available upon request from the corresponding author.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 07, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness
Amiel A. Dror, Nicole G. Morozov, Amani Daoud, Yoav Namir, Yakir Orly, Yair Shachar, Mark Lifshitz, Ella Segal, Lior Fischer, Matti Mizrachi, Netanel Eisenbach, Doaa Rayan, Maayan Gruber, Amir Bashkin, Edward Kaykov, Masad Barhoum, Michael Edelstein, Eyal Sela
medRxiv 2021.06.04.21258358; doi: https://doi.org/10.1101/2021.06.04.21258358
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness
Amiel A. Dror, Nicole G. Morozov, Amani Daoud, Yoav Namir, Yakir Orly, Yair Shachar, Mark Lifshitz, Ella Segal, Lior Fischer, Matti Mizrachi, Netanel Eisenbach, Doaa Rayan, Maayan Gruber, Amir Bashkin, Edward Kaykov, Masad Barhoum, Michael Edelstein, Eyal Sela
medRxiv 2021.06.04.21258358; doi: https://doi.org/10.1101/2021.06.04.21258358

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (549)
  • Anesthesia (134)
  • Cardiovascular Medicine (1747)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (310)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (653)
  • Epidemiology (10780)
  • Forensic Medicine (8)
  • Gastroenterology (584)
  • Genetic and Genomic Medicine (2933)
  • Geriatric Medicine (286)
  • Health Economics (531)
  • Health Informatics (1918)
  • Health Policy (833)
  • Health Systems and Quality Improvement (743)
  • Hematology (290)
  • HIV/AIDS (627)
  • Infectious Diseases (except HIV/AIDS) (12496)
  • Intensive Care and Critical Care Medicine (684)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (321)
  • Neurology (2780)
  • Nursing (150)
  • Nutrition (431)
  • Obstetrics and Gynecology (554)
  • Occupational and Environmental Health (597)
  • Oncology (1454)
  • Ophthalmology (440)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (379)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (362)
  • Primary Care Research (333)
  • Psychiatry and Clinical Psychology (2630)
  • Public and Global Health (5338)
  • Radiology and Imaging (1002)
  • Rehabilitation Medicine and Physical Therapy (594)
  • Respiratory Medicine (722)
  • Rheumatology (329)
  • Sexual and Reproductive Health (288)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)